The Recall Desk
LowFDA (Devices)·Z-1188-2019·Announced 2019-04-24

Aniara Recalls BIOPHEN UFH Control C2 Due to Incorrect Instructions

Aniara Diagnostica LLC is recalling 14 kits of BIOPHEN UFH Control C2 because incorrect Instructions for Use were packaged with the product.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a documentation error (incorrect instructions) rather than a defect in the device itself.

Plain-English summary

Aniara Diagnostica LLC is recalling 14 kits of BIOPHEN UFH Control C2, Reference 223901, Lot F1700315P7. The recall was initiated because the manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.

The affected products were distributed to accounts in Michigan and Pennsylvania. The source text does not specify the exact nature of the errors in the instructions or whether any adverse events have occurred.

Consumers and healthcare providers with this specific lot number should stop using the product and contact the manufacturer for further instructions or a replacement.

The recalled product

Product
BIOPHEN UFH Control C2, REF 223901
Affected units
14

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot F1700315P7

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 3 recalled by Aniara Diagnostica LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →